Results 1 to 10 of about 70,426 (210)

Human parainfluenza virus surveillance in pediatric patients with lower respiratory tract infections: a special view of parainfluenza type 4

Jornal De Pediatria, 2018
Objective: Characterize the role of human parainfluenza virus and its clinical features in Brazilian children under 2 years of age presenting with acute lower respiratory tract infections.
Thomazelli Lm
exaly   +6 more sources

Insights Into monoclonal antibodies and vaccines targeting respiratory viruses [PDF]

Frontiers in Pediatrics
IntroductionViral respiratory infections are a leading cause of morbidity and mortality in children worldwide, with lower respiratory tract infections (LRTIs) a major contributor to hospitalizations and healthcare utilization. Among respiratory pathogens,
Antonella Gambadauro, Giovanna A. Piedimonte, Sara Manti, Giovanni Piedimonte   +3 more
doaj   +2 more sources

European and American Strains of Porcine Parainfluenza Virus 1 (PPIV-1) Belong to Two Distinct Genetic Lineages

Pathogens, 2022
Porcine parainfluenza virus 1 (PPIV-1) is a recently emerged respirovirus closely related to human parainfluenza virus 1 (HPIV-1) and Sendai virus (SenV).
Tomasz Stadejek, Piotr Cybulski, Phillip C. Gauger, Aleksandra Woźniak   +3 more
doaj   +1 more source

Study of the medicine MestaMidin®-nos virucidal activity of against influenza and ARD pathogens

Медицинский совет, 2021
Introduction. Respiratory diseases have always been a serious threat to public health, but in 2020 the situation deteriorated significantly due to the rapid development of the coronavirus infection COVID-19.
A. A. Shtro, A. V. Galochkina, Yu. V. Nikolaeva, G. D. Petukhova, V. A. Fedorova, D. A. Lioznov   +5 more
doaj   +1 more source

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1

Frontiers in Immunology, 2020
Human Parainfluenza Virus-3 (HPIV3) causes severe respiratory illness in immunocompromised patients and lacks approved anti-viral therapies. A phase I study of adoptively transferred virus-specific T-cells (VSTs) targeting HPIV3 following bone marrow ...
Katherine M. Harris, Katherine M. Harris, Sarah E. Horn, Melanie L. Grant, Haili Lang, Gelina Sani, Mariah A. Jensen-Wachspress, Vaishnavi V. Kankate, Anushree Datar, Christopher A. Lazarski, Catherine M. Bollard, Catherine M. Bollard, Catherine M. Bollard, Michael D. Keller, Michael D. Keller, Michael D. Keller   +15 more
doaj   +1 more source

Multifaceted approach to treatment of acute respiratory viral infections

Клинический разбор в общей медицине, 2023
According to the World Health Organization, acute respiratory viral infections (ARVIs) account for 70–85% of all cases of infectious diseases in the world.
Elena N. Popova, Liubov A. Ponomareva, Alina A. Chinova, Aleksandr I. Andrianov   +3 more
doaj   +1 more source

Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020–2021

Viruses, 2022
Many countries have implemented public health and social measures (PHSMs) to control the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Chiara Achangwa, Huikyung Park, Sukhyun Ryu, Moo-Sik Lee   +3 more
doaj   +1 more source

Laboratory diagnostics acute respiratory virus infections under evolutionary variability influenza viruses

Журнал инфектологии, 2014
As a result of laboratory investigation 1651 patients at the age from 0 months till 18 years, hospitalized with ARI from 2008 to 2011, in ¾ cases the virus etiology of disease was found.
V. F. Suhovetskaya, E. A. Dondurey, V. P. Drinevsky, A. A. Sominina, V. G. Majorova, M. M. Pisareva, T. M. Gudkova, I. V. Amosova, V. Z. Krivitskaya, A. K. Golovanova   +9 more
doaj   +1 more source

Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009

Viruses, 2009
On 17 April 2009, novel swine origin influenza A virus (S-OIV) cases appeared within the United States. Most influenza A diagnostic assays currently utilized in local clinical laboratories do not allow definitive subtype determination.
Swati Kumar, Michael J. Chusid, Rodney E. Willoughby, Peter L. Havens, Sue C. Kehl, Nathan A. Ledeboer, Shun-Hwa Li, Kelly J. Henrickson   +7 more
doaj   +1 more source

Study of the Mechanism of Antiviral Activity of Cytovir®-3 Against Respiratory Viruses In Vitro

Антибиотики и Химиотерапия, 2023
Introduction. The requirements of modern clinical guidelines for the treatment of respiratory viral infections suggest the possibility of identifying a specific viral pathogen.
V. V. Zarubaev, V. S. Smirnov, T. A. Kudryavtseva, S. V. Petlenko, A. V. Slita, H. Minh, V. A. Zaplutanov   +6 more
doaj   +1 more source